Advitech Announces Agreement With Cothera To Market Its Psoriasis Product In France

Advitech Announces Agreement With Cothera To Market Its Psoriasis Product In France Company has reached an agreement in principle with Cothera® s.a.s. to market and distribute its psoriasis product in France.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Global Nutraceuticals Group named Exclusive US Distributor of PhytoShield(TM) Toothpastes The New Zealand Natural Oral Care Company announced it has named Global Nutraceuticals Group of San Francisco, California Exclusive US Wholesale Distributor for its PhytoShield(TM) science-based, non-flouridated toothpastes. American Oriental Bioengineering, Inc. Closes $60 Million Private Placement Company has closed its private offering to accredited investors of 12.5 million units at a price of $4.80 per unit, for gross proceeds of $60 million which will be used for potential acquisitions and general corporate purposes. American Oriental Bioengineering, Inc. Closes $60 Million Private Placement Company has closed its private offering to accredited investors of 12.5 million units at a price of $4.80 per unit, for gross proceeds of $60 million which will be used for potential acquisitions and general corporate purposes. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. Immune System Management Inc. purchases intellectual property to market nutraceutical compounds Company has purchased intellectual property pertaining to Aminomics developed by William O'Neill, the founder and CEO of the Canadian Cancer Research Group. Immune System Management Inc. purchases intellectual property to market nutraceutical compounds Company has purchased intellectual property pertaining to Aminomics developed by William O'Neill, the founder and CEO of the Canadian Cancer Research Group. Jarrow Formulas® Signs Agreement With CareNet China Company has signed an agreement to be a major supplier of nutritional supplements to CareNet China, a Chinese health care company. Jarrow Formulas® Signs Agreement With CareNet China Company has signed an agreement to be a major supplier of nutritional supplements to CareNet China, a Chinese health care company. Martek Announces Fourth Quarter and FY 2005 Financial Results Company reports revenues of $56.0 million compared to $59.7 million for the fourth quarter of fiscal 2004 , with income before income taxes of $7.7 million compared to income before income taxes of $10.1 million for the same quarter prior year. Martek Announces Fourth Quarter and FY 2005 Financial Results Company reports revenues of $56.0 million compared to $59.7 million for the fourth quarter of fiscal 2004 , with income before income taxes of $7.7 million compared to income before income taxes of $10.1 million for the same quarter prior year. Cyanotech Names William R. Maris as CFO Company has named William R. Maris as Chief Financial Officer and Vice President of Finance and Administration, effective January 1, 2006. Cyanotech Names William R. Maris as CFO Company has named William R. Maris as Chief Financial Officer and Vice President of Finance and Administration, effective January 1, 2006. Cyanotech Names William R. Maris as CFO Company has named William R. Maris as Chief Financial Officer and Vice President of Finance and Administration, effective January 1, 2006. Cyanotech Names William R. Maris as CFO Company has named William R. Maris as Chief Financial Officer and Vice President of Finance and Administration, effective January 1, 2006. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Biogaia Enters Into Agreements For New Indication Area Chr. Hansen A/S the Danish Food ingredient company, Urex Biotech Inc. a Canadian research company and BioGaia the Swedish probiotic company have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. Hain Celestial Closes Merger With Spectrum Organic Products Company announced that it has completed its merger with Spectrum Organic Products, Inc. Hain Celestial Closes Merger With Spectrum Organic Products Company announced that it has completed its merger with Spectrum Organic Products, Inc. Celanese Has Sold Its omega-3 DHA Business to Lonza Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed. Celanese Has Sold Its omega-3 DHA Business to Lonza Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed. Celanese Has Sold Its omega-3 DHA Business to Lonza Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed. Celanese Has Sold Its omega-3 DHA Business to Lonza Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed. Agreement Between Clover Corporation Ltd, the CSIRO Food Futures Flagship and the CRC for Bioproducts To Evaluate Potential of Marine Oils Oil-rich marine microalgae are being assessed for their commercial potential under a new agreement between Clover Corporation Ltd, the CSIRO Food Futures Flagship and the CRC for Bioproducts. Agreement Between Clover Corporation Ltd, the CSIRO Food Futures Flagship and the CRC for Bioproducts To Evaluate Potential of Marine Oils Oil-rich marine microalgae are being assessed for their commercial potential under a new agreement between Clover Corporation Ltd, the CSIRO Food Futures Flagship and the CRC for Bioproducts. Forage Genetics, Inc. and NuTein Companies, Inc., Announce Agreement on Identifying Alfalfa with Enhanced Lutein levels Under the new agreement, Forage Genetics will provide NuTein with support including the identification of alfalfa germplasm containing higher levels of Lutein, protocol development for ISO compliance for growing and harvesting of alfalfa, crop management of alfalfa to maximize Lutein levels, and delivery of the improved alfalfa crop to NuTein for the purposes of processing the alfalfa into Lutein. Forage Genetics, Inc. and NuTein Companies, Inc., Announce Agreement on Identifying Alfalfa with Enhanced Lutein levels Under the new agreement, Forage Genetics will provide NuTein with support including the identification of alfalfa germplasm containing higher levels of Lutein, protocol development for ISO compliance for growing and harvesting of alfalfa, crop management of alfalfa to maximize Lutein levels, and delivery of the improved alfalfa crop to NuTein for the purposes of processing the alfalfa into Lutein. Biogaia Signs Agreement For Hospital Distribution In The USA Company has signed an agreement with the American company Victus Inc to distribute Reuteri tablets and Reuteri drops for the US hospital market. Biogaia Signs Agreement For Hospital Distribution In The USA Company has signed an agreement with the American company Victus Inc to distribute Reuteri tablets and Reuteri drops for the US hospital market. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO(TM) Launch, in Japan Company announces a new Glucosamine/NKO(TM) blend to be launched in Japan through a strategic partnership with Koyo Chemical Co., Ltd. with Neptune to exclusively introduce the Joint Health Complex to the North American and European markets. Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain. SunOpta Inc. Announces Acquisition of Les Importations Cacheres Hahamovitch Inc. Company has announced that it has acquired 100% of the outstanding shares of 4307623 Canada Inc. into which has been transferred the business, operating assets and liabilities of the business of Les Importations Cacheres Hahamovitch Inc. SunOpta Inc. Announces Acquisition of Les Importations Cacheres Hahamovitch Inc. Company has announced that it has acquired 100% of the outstanding shares of 4307623 Canada Inc. into which has been transferred the business, operating assets and liabilities of the business of Les Importations Cacheres Hahamovitch Inc. SunOpta Inc. Announces Acquisition of Les Importations Cacheres Hahamovitch Inc. Company has announced that it has acquired 100% of the outstanding shares of 4307623 Canada Inc. into which has been transferred the business, operating assets and liabilities of the business of Les Importations Cacheres Hahamovitch Inc. SunOpta Inc. Announces Acquisition of Les Importations Cacheres Hahamovitch Inc. Company has announced that it has acquired 100% of the outstanding shares of 4307623 Canada Inc. into which has been transferred the business, operating assets and liabilities of the business of Les Importations Cacheres Hahamovitch Inc. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. Integrity Nutraceuticals Experiences Record Growth in 2005 Overall company sales increased by 146 percent in 2005, with company expanding its office and warehouse space by 6,500 square feet in June 2005. Integrity Nutraceuticals Experiences Record Growth in 2005 Overall company sales increased by 146 percent in 2005, with company expanding its office and warehouse space by 6,500 square feet in June 2005. Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Kashi Company Introduces TLC™ Fruit & Grain Bars Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars. Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009 Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status. KGK Synergize Inc. Announces GRAS Status For Sytrinol® KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.	QUÉBEC – December 15, 2005 - Advitech Inc. (TSX-V: AVI) today announced it has reached an agreement in principle (the “Agreement”) with Cothera® s.a.s. (“Cothera”), a French company specializing in the marketing of co-therapies for chronic diseases, to market and distribute its psoriasis product in France. The Agreement is subject to a definitive marketing and distribution contract (the “Contract”), to be entered into before June 30, 2006. The Contract will give Cothera exclusive rights from Advitech to market Dermylex™, Advitech’s clinically tested, bioactive ingredient for the treatment of psoriasis. The Contract will have a term of three years, and will provide for a certain minimum amount of product purchases to be reached by Cothera in order to maintain exclusivity from Advitech. In addition, Cothera has agreed to a marketing program that includes specific objectives regarding coverage of dermatologists in France. Other financial terms and conditions of the Agreement were not disclosed. Cothera is a company headed by three former senior executives of large pharmaceutical companies. François Miceli, one of Cothera’s co-founders and its non-executive Chairman, is the former CEO of IDEXX Laboratories Italia, a subsidiary of IDEXX Laboratories (NASDAQ: IDXX). Dominique Bourgeade, co-founder and Chief Operating Officer, is the former Head of the Pharmaceutical Division of Pharmacia France, a company now part of Pfizer (NYSE: PFE). J.C. Anton, co-founder and Chief Scientific Officer, was previously Marketing Director of Pierre Fabre Laboratories, France. Commenting on the Agreement, Cothera Chairman François Miceli mentioned: “We are very pleased to have reached this agreement with Advitech. Advitech’s psoriasis product fits our mission of improving patient quality of life perfectly, by providing clinically proven nutraceutical products. Cothera believes in the importance of co-therapies where a nutraceutical product like Advitech’s can complement existing drugs by providing safe, effective and convenient solutions.“Renaud Beauchesne, CEO of Advitech, added: “This agreement with Cothera for our psoriasis product is important because it validates our strategy to market clinically proven, naturally-derived products. We are looking forward to having Cothera introduce our product to market before the end of 2006 and accelerate its sales and marketing effort in 2007.“ Product Launch Timetable COO Dominique Bourgeade indicated that Cothera intends to file its dossier with the French regulatory authorities during the first quarter of 2006 and, subject to the necessary approvals, it is planning a product launch before the end of 2006. About Cothera Cothera® s.a.s. (www.cothera.com) is a French-based company that develops, manufactures and markets proprietary nutraceutical formulations through health care professionals to people at risk or suffering from neurodegenerative and/or chronic diseases, as a complementary integrated treatment that is given in conjunction with allopathic treatment. About Dermylex™ Dermylex™ is Advitech’s orally administered product for mild to moderate psoriasis with proven clinical efficacy. On July 5, 2005, the Company reported positive results from its Phase II clinical trial for mild to moderate psoriasis. The 112-day, multi-center, double blind, placebo-controlled study, involving 84 patients, confirmed the efficacy and excellent safety profile of Dermylex™ for treating mild to moderate psoriasis. About Advitech Advitech is a Canadian biotechnology company specializing in the development of clinically tested bioactive ingredients for chronic immune-mediated inflammatory diseases (I.M.I.D.), such as psoriasis and inflammatory bowel diseases. Advitech’s common shares are listed on the TSX Venture Exchange under the symbol AVI. The number of common shares outstanding is 54,799,818. -30- This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software